Detalhe da pesquisa
1.
L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.
Am J Med Genet A
; 185(10): 2976-2985, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34155781
2.
Dietary intervention rescues myopathy associated with neurofibromatosis type 1.
Hum Mol Genet
; 27(4): 577-588, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29228356
3.
Developmental dosing with a MEK inhibitor (PD0325901) rescues myopathic features of the muscle-specific but not limb-specific Nf1 knockout mouse.
Mol Genet Metab
; 123(4): 518-525, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29477258
4.
Dietary intervention rescues a bone porosity phenotype in a murine model of Neurofibromatosis Type 1 (NF1).
PLoS One
; 19(6): e0304778, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38913608
5.
Murine models of orthopedic infection featuring Staphylococcus aureus biofilm.
J Bone Jt Infect
; 8(2): 81-89, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37123502
6.
Combination treatment with growth hormone and zoledronic acid in a mouse model of Osteogenesis imperfecta.
Bone
; 159: 116378, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35257929
7.
Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.
J Biomed Opt
; 26(12)2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34935315
8.
Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1).
PLoS One
; 15(8): e0237097, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32810864
9.
Lipid storage myopathies: Current treatments and future directions.
Prog Lipid Res
; 72: 1-17, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30099045